RhumbLine Advisers
MDWD icon

RhumbLine Advisers’s MediWound MDWD Stock Holding History

RhumbLine Advisers’s Portfolio MDWD Stock Details MDWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$178K Buy
12,128
+807
+7% +$12.8K ﹤0.01% 3331
2026
Q1 		$182K Buy
11,321
+456
+4% +$7.93K ﹤0.01% 3172
2025
Q4 		$201K Buy
10,865
+65
+0.6% +$1.19K ﹤0.01% 3175
2025
Q3 		$195K Sell
10,800
-1,504
-12% -$27.7K ﹤0.01% 3232
2025
Q2 		$238K Buy
12,304
+988
+9% +$18.6K ﹤0.01% 3134
2025
Q1 		$176K Buy
11,316
+481
+4% +$8.61K ﹤0.01% 3173
2024
Q4 		$193K Buy
10,835
+739
+7% +$12.7K ﹤0.01% 3215
2024
Q3 		$182K Buy
10,096
+1,656
+20% +$30.2K ﹤0.01% 3281
2024
Q2 		$131K Buy
+8,440
New +$140K ﹤0.01% 3428

Other funds holding MDWD

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $527M AUM 50.16% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RhumbLine Advisers's MDWD Position: Q2 2026 in Review

RhumbLine Advisers increased its MediWound (MDWD) stake by 7.1% in Q2 2026, buying an estimated $12.8K and bringing the position to 12,128 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #3331.

RhumbLine Advisers first reported a position in MDWD in Q2 2024 and has held it in 9 quarters since. The position peaked at $238K in Q2 2025. 79 funds tracked by Wall St. Rank hold MDWD as of Q2 2026.

  • RhumbLine Advisers held 12,128 shares of MediWound worth $178K as of Q2 2026.
  • RhumbLine Advisers bought 807 MediWound shares in Q2 2026, an estimated $12.8K.
  • MediWound made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3331 holding.
  • RhumbLine Advisers first reported a position in MediWound in Q2 2024 and has held it in 9 quarters since.
  • RhumbLine Advisers's MediWound position peaked at $238K in Q2 2025.
  • 79 funds tracked by Wall St. Rank held MediWound as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.